Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/Hyperinsulinemia

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1692-1696

  Laughlin, G A ^a   Morales, A J ^a   Yen, S S C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; PROTEIN;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; ENDOCRINE GLAND; FEMALE; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; METABOLISM; OSMOLARITY; OVARY POLYCYSTIC DISEASE; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; ENDOCRINE GLANDS; FEMALE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; LEPTIN; OSMOLAR CONCENTRATION; POLYCYSTIC OVARY SYNDROME; PROTEINS;

EID: 0031156840     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.6.1692     Document Type: Article

References (38)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432 [Erratum, Nature 1995:374:479].
2. Mazsuzaki H, Ogawa Y, Isse N, et al. 1995 Human obese gene expression. Adipocyte specific expression and regional differences in the adipose tissue. Diabetes. 44:855-858.
3. Leroy P, Dessolin S, Villageois P, et al. 1996 Expression of ob gene in adipose cells: regulation by insulin. J Biol Chem. 271:2365-2368.
4. Saladin R, DeVis P, Guerre-Millo M, et al. 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:527-529.
5. MacDougald OA, Hwang CS, Fan HY, Lane MD. 1995 Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proc Nat Acad Sci USA. 92:9034-9037.
6. Trayburn P, Thomas MEA, Duncan JS, Rayner DV. 1995 Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (ob/ob) mice. FEBS Lett. 368:488-490.
7. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. 1995 The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes. 44:1467-1470.
8. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med. 1:1155-1161.
9. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med. 334:292-295.
10. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. 1996 Radioimmunoassay of leptin in human plasma. Clin Chem. 42:942-946.
11. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. 1996 Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 81:4406-4413.
12. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL. 1997 Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab. 82:561-565.
13. Kopelman PG. 1994 Hormones and obesity. Baillieres Clin Endocrinol Metab. 8:549-575.
14. Kolaczynski JW, Nyce MR, Considine RV, et al. 1996 Acute and chronic effect of insulin on leptin production in humans. Diabetes. 45:699-701.
15. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, et al. 1996 Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes. 45:1435-1438.
16. Malmström R, Taskinen M-R, Karonen S-L, Yki-Järvinen H. 1996 Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia. 39:993-996.
17. Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. 1996 Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes. 45:1364-1366.
18. Vidal H, Aubouef D, De Vos P, Staels B, et al. 1996 The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J. Clin. Invest. 98:251-255.
19. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. 1996 Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes. 45:695-698.
20. Caprio S, Tamborlane WV, Silver D, Robinson C, et al. 1996 Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. Am J Physiol. 271:E626-E630.
21. Segal KR, Landt M, Klein S. 1996 Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 45:988-991.
22. Larsson H, Elmståhl S, Ahrén B. 1996 Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes. 45:1580-1584.
23. Pratley RE, Nicolson M, Bogardus C, Ravussin E. 1996 Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. J Clin Endocrinol Metab. 81:4418-4421.
24. Ryan AS, Elahi D. 1996 The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral adiposity, and age in women. J Clin Endocrinol Metab. 81:4433-4438.
25. Laughlin GA, Yen SSC. 1997 Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab. 82:318-321.
26. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. 1997 UKPDS 20:Plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab. 82:654-657.
27. Dua A, Hennes MI, Hoffman RG, Maas DL, et al. 1996 Leptin: A significant indicator of total body fat but not of visceral tat and insulin insensitivity in African-American women. Diabetes. 45:1635-1637.
28. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165-1174.
29. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SSC. 1992 Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 75:577-583.
30. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41:1257-1266.
31. Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SSC. 1996. Insulin, somatotrophic and LH axes in lean and obese women with polycystic ovary syndrome (PCOS): common and distinct features. J Clin Endocrinol Metab. 81:2854-2864.
32. Rosenbaum D, Haber RS, Dunaif A. 1993 Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Amer J Physiol. 264:E197-202.
33. Dunaif A, Xia J, Book CB, Schenker E, Tang Z. 1995 Excessive insulin eceptor serine phoshorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary. J Clin Invest. 96(2):801-810.
34. Bergman RN, Prager R, Volund A, Olefsky JM. 1987 Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 79:790-800.
35. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486-490.
36. Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SR, Buyalos RP, Magoffin DA. 1996 Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 81:4166-4169.
37. Barash IA, Cheung CC, Weigle DS, et al. 1996 Leptin is a metabolic signal to the reproductive system. Endocrinology. 137:3144-3147.
38. Ahima RS, Prabakaran D, Mantzoros C, et al. 1996 Role of leptin in the neuroendocrine response to fasting. Nature. 382:250-252.